Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for recall
Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for IN VITRO DIAGNOSTIC USE in the quantitative determination of analytes. These are CONSUMABLES…
Why was Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for recalled?
Sterling Diagnostics, Inc. initiated a recall on 7/20/2016 for multiple diagnostic kits due to a recision of the previously extended expiration dates for the kits.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Creatinine/Endpoint [Modified Heinegard-Tiderstrom], CAT No. 2167-O, Lot No. 16751, Expriry: 5/18, Manufactured: 06/02/15
- Product
- Creatinine/Endpoint [Modified Heinegard-Tiderstrom] for IN VITRO DIAGNOSTIC USE in the quantitative determination of analytes. These are CONSUMABLES…
- Recalling firm
- Sterling Diagnostics, Inc.
- Quantity
- 182
- Distribution
- Domestic: MI Foreign: Phillipines VA/DOD: None
- Recall date
- January 4, 2017
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (device)